Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 2.137 | 103 | 94 | 232 | 8928 | 1118 | 220 | 4.78 | 94.98 | 36.19 | |
2 | Current Alzheimer Research | journal | 1.608 Q1 | 103 | 96 | 223 | 7678 | 1088 | 211 | 4.52 | 79.98 | 36.98 | |
3 | Current Protein and Peptide Science | journal | 1.489 Q1 | 96 | 76 | 170 | 7147 | 626 | 156 | 2.96 | 94.04 | 39.73 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 1.468 Q1 | 96 | 99 | 188 | 10725 | 777 | 168 | 4.07 | 108.33 | 33.55 | |
5 | Current Topics in Medicinal Chemistry | journal | 1.351 Q1 | 133 | 229 | 445 | 24674 | 1905 | 377 | 3.84 | 107.75 | 33.44 | |
6 | Current Gene Therapy | journal | 1.347 Q2 | 80 | 50 | 132 | 6077 | 671 | 123 | 3.90 | 121.54 | 35.43 | |
7 | Current Genomics | journal | 1.332 Q2 | 77 | 60 | 182 | 5679 | 574 | 178 | 2.85 | 94.65 | 40.78 | |
8 | Current Neuropharmacology | journal | 1.309 Q1 | 103 | 94 | 102 | 7032 | 445 | 97 | 3.51 | 74.81 | 35.27 | |
9 | Current Diabetes Reviews | journal | 1.103 Q1 | 68 | 49 | 117 | 4371 | 428 | 115 | 3.54 | 89.20 | 36.81 | |
10 | Current Stem Cell Research and Therapy | journal | 1.078 Q1 | 63 | 35 | 116 | 3844 | 396 | 112 | 3.22 | 109.83 | 42.28 | |
11 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.997 Q1 | 52 | 33 | 70 | 4134 | 212 | 70 | 3.40 | 125.27 | 44.66 | |
12 | Current Neurovascular Research | journal | 0.944 | 60 | 32 | 96 | 1980 | 311 | 96 | 3.16 | 61.88 | 45.10 | |
13 | Current Vascular Pharmacology | journal | 0.944 Q1 | 69 | 74 | 182 | 7940 | 580 | 169 | 3.21 | 107.30 | 24.70 | |
14 | Mini-Reviews in Medicinal Chemistry | journal | 0.855 Q1 | 107 | 108 | 395 | 10227 | 1177 | 393 | 2.84 | 94.69 | 37.46 | |
15 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.753 Q2 | 63 | 32 | 104 | 3596 | 262 | 101 | 2.14 | 112.38 | 34.21 | |
16 | Current Clinical Pharmacology | journal | 0.752 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
17 | Reviews on Recent Clinical Trials | journal | 0.718 Q2 | 35 | 30 | 75 | 2410 | 171 | 74 | 2.31 | 80.33 | 34.23 | |
18 | Combinatorial Chemistry and High Throughput Screening | journal | 0.645 Q2 | 70 | 93 | 284 | 4945 | 645 | 256 | 2.00 | 53.17 | 28.18 | |
19 | Current Nanoscience | journal | 0.582 Q2 | 52 | 135 | 212 | 6698 | 464 | 212 | 1.94 | 49.61 | 30.43 | |
20 | Current Computer-Aided Drug Design | journal | 0.531 Q2 | 32 | 32 | 74 | 2728 | 163 | 70 | 1.91 | 85.25 | 31.40 | |
21 | Current Cardiology Reviews | journal | 0.529 Q2 | 58 | 36 | 124 | 2123 | 144 | 122 | 1.05 | 58.97 | 30.68 | |
22 | Current Drug Safety | journal | 0.526 Q2 | 41 | 57 | 112 | 2359 | 238 | 102 | 2.05 | 41.39 | 34.64 | |
23 | Current Nutrition and Food Science | journal | 0.334 Q3 | 32 | 36 | 89 | 2672 | 84 | 85 | 1.09 | 74.22 | 48.51 | |
24 | Open Cardiovascular Medicine Journal | journal | 0.323 Q3 | 32 | 36 | 71 | 1962 | 89 | 69 | 1.25 | 54.50 | 27.95 | |
25 | Current Radiopharmaceuticals | journal | 0.226 Q3 | 32 | 40 | 55 | 2644 | 35 | 50 | 0.64 | 66.10 | 25.20 | |
26 | Current Medical Imaging | journal | 0.208 Q3 | 37 | 40 | 110 | 2684 | 49 | 98 | 0.49 | 67.10 | 25.44 | |
27 | Current Drug Therapy | journal | 0.197 Q3 | 20 | 33 | 84 | 2889 | 58 | 81 | 0.59 | 87.55 | 37.18 | |
28 | Current Rheumatology Reviews | journal | 0.189 Q3 | 29 | 42 | 134 | 2628 | 61 | 116 | 0.46 | 62.57 | 32.00 | |
29 | Current Hypertension Reviews | journal | 0.181 Q3 | 27 | 38 | 100 | 2530 | 53 | 98 | 0.57 | 66.58 | 31.82 | |
30 | Current Pediatric Reviews | journal | 0.181 Q3 | 33 | 46 | 103 | 3160 | 37 | 97 | 0.29 | 68.70 | 50.00 | |
31 | Current Respiratory Medicine Reviews | journal | 0.178 Q3 | 15 | 59 | 132 | 3789 | 46 | 117 | 0.30 | 64.22 | 29.25 | |
32 | Current Cancer Therapy Reviews | journal | 0.143 Q4 | 17 | 28 | 104 | 3131 | 34 | 102 | 0.35 | 111.82 | 35.44 | |
33 | Current Women's Health Reviews | journal | 0.137 Q3 | 16 | 53 | 114 | 3582 | 29 | 102 | 0.26 | 67.58 | 58.76 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®